AAAAAA

   
Results: 1-22 |
Results: 22
VARIABLES ASSOCIATED WITH THE PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUSPERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION
Authors: BOLWELL B GOORMASTIC M ANDRESEN S KOO A WISE K OVERMOYER B POHLMAN B KALAYCIO M
Citation: B. Bolwell et al., VARIABLES ASSOCIATED WITH THE PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUSPERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION, Bone marrow transplantation, 22(6), 1998, pp. 547-551
DELAYED G-CSF AFTER AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL
Authors: BOLWELL BJ POHLMAN B ANDRESEN S KALAYCIO M GOORMASTIC M WISE K WAKELING A DANNLEY R OVERMOYER B
Citation: Bj. Bolwell et al., DELAYED G-CSF AFTER AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL, Bone marrow transplantation, 21(4), 1998, pp. 369-373
A RANDOMIZED STUDY OF MULTI-DAY INFUSION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: ABDELRAZEQ H POHLMAN B ANDRESEN S KALAYCIO M OVERMOYER B WISE K DANNLEY R DEMARS D GOORMASTIC M BOLWELL B
Citation: H. Abdelrazeq et al., A RANDOMIZED STUDY OF MULTI-DAY INFUSION OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS, Bone marrow transplantation, 21(3), 1998, pp. 221-223
CONTINUOUS-INFUSION GRANISETRON COMPARED TO ONDANSETRON FOR THE PREVENTION OF NAUSEA AND VOMITING AFTER HIGH-DOSE CHEMOTHERAPY
Authors: KALAYCIO M MENDEZ Z POHLMAN B OVERMOYER B BOPARAI N JONES E BOLWELL B
Citation: M. Kalaycio et al., CONTINUOUS-INFUSION GRANISETRON COMPARED TO ONDANSETRON FOR THE PREVENTION OF NAUSEA AND VOMITING AFTER HIGH-DOSE CHEMOTHERAPY, Journal of cancer research and clinical oncology, 124(5), 1998, pp. 265-269
RANDOMIZED PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 TO PREVENT CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH BREAST-CANCER RECEIVING DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN
Authors: ISAACS C ROBERT NJ BAILEY FA SCHUSTER MW OVERMOYER B GRAHAM M CAI B BEACH KJ LOEWY JW KAYE JA
Citation: C. Isaacs et al., RANDOMIZED PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN INTERLEUKIN-11 TO PREVENT CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA IN PATIENTS WITH BREAST-CANCER RECEIVING DOSE-INTENSIVE CYCLOPHOSPHAMIDE AND DOXORUBICIN, Journal of clinical oncology, 15(11), 1997, pp. 3368-3377
PROGRESSIVE DISEASE AFTER ABMT FOR HODGKINS-DISEASE
Authors: BOLWELL BJ KALAYCIO M GOORMASTIC M DANNLEY R ANDRESEN SW LICHTIN A OVERMOYER B POHLMAN B
Citation: Bj. Bolwell et al., PROGRESSIVE DISEASE AFTER ABMT FOR HODGKINS-DISEASE, Bone marrow transplantation, 20(9), 1997, pp. 761-765
PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT
Authors: BOLWELL BJ GOORMASTIC M ANDRESEN S OVERMOYER B POHLMAN B KALAYCIO M
Citation: Bj. Bolwell et al., PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT, Bone marrow transplantation, 20(6), 1997, pp. 459-463
G-CSF POST-AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A RANDOMIZED STUDY OF 5, 10, AND 16 MU-G KG/DAY/
Authors: BOLWELL B GOORMASTIC M DANNLEY R ANDRESEN S OVERMOYER B MENDEZ Z KALAYCIOGLU M DEMARS D WISE K POHLMAN B
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A RANDOMIZED STUDY OF 5, 10, AND 16 MU-G KG/DAY/, Bone marrow transplantation, 19(3), 1997, pp. 215-219
FACTORS ASSOCIATED WITH DELAYED G-CSF PRIMED PBPC COLLECTION
Authors: BOLWELL B OVERMOYER B KALAYCIO M GOORMASTIC M ANDRESEN S DANNLEY R WISE K DEMARS D POHLMAN B
Citation: B. Bolwell et al., FACTORS ASSOCIATED WITH DELAYED G-CSF PRIMED PBPC COLLECTION, Blood, 90(10), 1997, pp. 4201-4201
THE G-CSF PRIMED WBC CORRELATES WITH CD34+ CELL YIELD
Authors: BOLWELL B POHLMAN B OVERMOYER B ANDRESEN S GOORMASTIC M DANNLEY R SERAFIN M LICHTIN A WISE K KALAYCIO M
Citation: B. Bolwell et al., THE G-CSF PRIMED WBC CORRELATES WITH CD34+ CELL YIELD, Blood, 90(10), 1997, pp. 4202-4202
BREAST-CANCER PATIENTS HAVE A HIGHER PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUS PBPC TRANSPLANT THAN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: BOLWELL B OVERMOYER B GOORMASTIC M KALAYCIO M ANDRESEN S DANNLEY R WISE K SERAFIN M WAKELING A POHLMAN B
Citation: B. Bolwell et al., BREAST-CANCER PATIENTS HAVE A HIGHER PLATELET COUNT 6 WEEKS AFTER AUTOLOGOUS PBPC TRANSPLANT THAN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Blood, 90(10), 1997, pp. 4348-4348
SAFETY AND BIOLOGIC EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN BREAST CANTER PATIENTS FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPC)
Authors: BOLWELL B VREDENBURGH J OVERMOYER B GILBERT C CHAP L MENCHACA D SCARLATA D GLASPY J
Citation: B. Bolwell et al., SAFETY AND BIOLOGIC EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN BREAST CANTER PATIENTS FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPC), Blood, 90(10), 1997, pp. 756-756
EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT
Authors: GLASPY J VREDENBURGH J DEMETRI GD CHAP L GILBERT C OVERMOYER B WARREN DL BERG R SCARLATA D MENCHACA D BOLWELL B
Citation: J. Glaspy et al., EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT, Blood, 90(10), 1997, pp. 2582-2582
EFFECTIVE TREATMENT FOR POOR-RISK ACUTE MYELOGENOUS LEUKEMIA (AML) - A POTENTIAL ROLE FOR TIMED SEQUENTIAL THERAPY WITH CONCOMITANT G-CSF
Authors: GEORGE C TRIPP B HUSSEIN M LICHTIN A ANDRESEN S OVERMOYER B POHLMAN B KALAYCIO M
Citation: C. George et al., EFFECTIVE TREATMENT FOR POOR-RISK ACUTE MYELOGENOUS LEUKEMIA (AML) - A POTENTIAL ROLE FOR TIMED SEQUENTIAL THERAPY WITH CONCOMITANT G-CSF, Blood, 88(10), 1996, pp. 3419-3419
STEM-CELL INFUSION OVER 2 OR 3 DAYS DOES NOT ENHANCE AUTOLOGOUS PROGENITOR-CELL TRANSPLANATION (ABMT) ENGRAFTMENT - A RANDOMIZED STUDY
Authors: ABDELRAZEQ H ANDRESEN S GOORMASTIC M KALAYCIO M OVERMOYER B WISE K DANNLEY R DEMARS D POHLMAN B BOLWELL B
Citation: H. Abdelrazeq et al., STEM-CELL INFUSION OVER 2 OR 3 DAYS DOES NOT ENHANCE AUTOLOGOUS PROGENITOR-CELL TRANSPLANATION (ABMT) ENGRAFTMENT - A RANDOMIZED STUDY, Blood, 88(10), 1996, pp. 453-453
PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION (ABMT) CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT
Authors: BOLWELL B ANDRESEN S KALAYCIO M DANNLEY R SERAFIN M WISE K MENDEZ Z OVERMOYER B GOORMASTIC M POHLMAN B
Citation: B. Bolwell et al., PLATELET TRANSFUSION REQUIREMENTS DURING AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION (ABMT) CORRELATE WITH THE PRETRANSPLANT PLATELET COUNT, Blood, 88(10), 1996, pp. 477-477
AN ANALYSIS OF PROGNOSTIC FEATURES IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST
Authors: FROST AR TERAHATA S YEH IT SIEGEL RS OVERMOYER B SILVERBERG SG
Citation: Ar. Frost et al., AN ANALYSIS OF PROGNOSTIC FEATURES IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST, Modern pathology, 8(8), 1995, pp. 830-836
G-CSF POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT - A RANDOMIZED STUDY OF 5, 10, AND 16 MCG D/
Authors: BOLWELL B GOORMASTIC M DANNLEY R ANDRESEN S OVERMOYER B POHLMAN B MENDEZ Z KALAYCIOGLU M DEMARS D WISE K
Citation: B. Bolwell et al., G-CSF POST-AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) TRANSPLANT - A RANDOMIZED STUDY OF 5, 10, AND 16 MCG D/, Blood, 86(10), 1995, pp. 2465-2465
ABMT FOR LARGE-CELL LYMPHOMA - MATURE FOLLOW-UP OF THE CBV PREPARATIVE REGIMEN
Authors: BOLWELL B ANDRESEN S LICHTIN A OVERMOYER B POHLMAN B GOORMASTIC M DANNLEY R MENDEZ Z WAKELING A
Citation: B. Bolwell et al., ABMT FOR LARGE-CELL LYMPHOMA - MATURE FOLLOW-UP OF THE CBV PREPARATIVE REGIMEN, Blood, 86(10), 1995, pp. 3740-3740
THE SIGNIFICANCE OF SIGNET-RING CELLS IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST
Authors: FROST AR TERAHATA S YEH IT SIEGEL RS OVERMOYER B SILVERBERG SG
Citation: Ar. Frost et al., THE SIGNIFICANCE OF SIGNET-RING CELLS IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST, Archives of pathology and laboratory medicine, 119(1), 1995, pp. 64-68
THE INFLUENCE OF YOUNG AGE ON OUTCOME IN EARLY-STAGE BREAST-CANCER
Authors: FOWBLE BL SCHULTZ DJ OVERMOYER B SOLIN LJ FOX K JARDINES L OREL S GLICK JH
Citation: Bl. Fowble et al., THE INFLUENCE OF YOUNG AGE ON OUTCOME IN EARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 30(1), 1994, pp. 23-33
THE INFLUENCE OF AGE ON OUTCOME IN EARLY-STAGE BREAST-CANCER
Authors: FOWBLE B SCHULTZ D OVERMOYER B JARDINES L SOLIN L GLICK J
Citation: B. Fowble et al., THE INFLUENCE OF AGE ON OUTCOME IN EARLY-STAGE BREAST-CANCER, International journal of radiation oncology, biology, physics, 27, 1993, pp. 148-149
Risultati: 1-22 |